You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 1, July 2, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Medical News & Perspectives
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Public Health, Other
 •Viral Infections
 •Alert me on articles by topic

Monkeypox Outbreak a Reminder of Emerging Infections Vulnerabilities

Joan Stephenson, PhD

JAMA. 2003;290:23-24.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is a scenario that has become all too familiar in recent years: an exotic microbe, aided by human travel and commerce, erupts in a new setting. In 1999, it was the West Nile virus. Earlier this year, severe acute respiratory syndrome (SARS) exploded on the world's stage. And last month, the first cases of monkeypox, a viral disease related to smallpox—but less deadly and less infectious—appeared in the Western hemisphere (see "From the Centers for Disease Control and Prevention" [CDC] article on page 30 in the printed journal).

Monkeypox is a rare zoonotic viral infection that occurs primarily in Central and West Africa. In those areas, limited person-to-person spread of the virus has been observed in household settings .

By June 13, at least 81 confirmed or possible cases of monkeypox infection in humans had been reported in four states—Wisconsin, Indiana, Illinois, and New Jersey. About . . . [Full Text of this Article]


RELATED ARTICLE

Multistate Outbreak of Monkeypox— Illinois, Indiana, and Wisconsin, 2003
JAMA. 2003;290(1):30-31.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8+ T-Cell Peptide Epitope of Vaccinia and Variola Viruses
Snyder et al.
J. Virol. 2004;78:7052-7060.
ABSTRACT | FULL TEXT  

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-{gamma}-producing T Cell Memory to Smallpox in Humans
Combadiere et al.
J. Exp. Med. 2004;199:1585-1593.
ABSTRACT | FULL TEXT  

Detection of Orthopoxvirus DNA by Real-Time PCR and Identification of Variola Virus DNA by Melting Analysis
Nitsche et al.
J. Clin. Microbiol. 2004;42:1207-1213.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.